Announcement PDF Notification of buy-back Announcement Summary Name of entity RESONANCE HEALTH LIMITED Announcement type New announcement Date of this announcement 24/11/2023 ASX Security code and description of the class of +securities the subject of the buy-back RHT : ORDINARY FULLY PAID The type of buy-back is: Selective buy-back Refer to next page for full details of the announcement Notification of buy-back 1/5 Notification of buy-back Part 1 - Entity and announcement details 1.1 Name of entity RESONANCE HEALTH LIMITED We (the entity named above) provide the following information about our buy-back. 1.2 Registration number type Registration number ACN 006762492 1.3 ASX issuer code RHT 1.4 The announcement is New announcement 1.5 Date of this announcement 24/11/2023 1.6 ASX Security code and description of the class of +securities the subject of the buy-back RHT : ORDINARY FULLY PAID Notification of buy-back 2/5 Notification of buy-back Part 2 - Type of buy-back 2.1 The type of buy-back is: Selective buy-back Notification of buy-back 3/5 Notification of buy-back Part 3 - Buy-back details Part 3A - Details of +securities, price and reason 3A.1 Total number of +securities on issue in the class of +securities to be bought back 466,892,928 3A.2 Total number of +securities proposed to be bought back 20,000,000 3A.3 Name of person or description of class of persons whose +securities are proposed to be bought back Acuity Capital Investment Management Pty Ltd atf Acuity Capital Holdings Trust 3A.9 Are the +securities being bought back for a cash consideration? No 3A.9b Please describe the consideration being provided to buy back the +securities Securities are being bought back for nil consideration pursuant to the terms of the Controlled Placement Deed (CPD) entered into by the Company with Acuity Capital Investment Management Pty Ltd atf Acuity Capital Holdings Trust, as announced to the market on 30 Apr 2019. The securities were issued as collateral shares pursuant to the CPD which expired on 31 Jul 2023. Shareholder approval was obtained for the selective buyback on 16 Nov 2023 (see the Notice of AGM dated 11 Oct 2023). Part 3B - Buy-back restrictions and conditions 3B.1 Does the buy-back require security holder approval? No 3B.2 Are there any restrictions on foreign participation in the buy-back No 3B.3 Are there any other conditions that need to be Notification of buy-back 4/5 Notification of buy-back 3B.3 Are there any other conditions that need to be satisfied before the buy-back offer becomes unconditional? No Part 3C - Key dates Employee Share Scheme, Selective and Other Buy-Backs 3C.1 Anticipated date buy-back will occur 11/12/2023 Part 3D - Other Information 3D.1 Any other information the entity wishes to notify to ASX about the buy-back Securities are being bought back for nil consideration pursuant to the terms of the Controlled Placement Deed (CPD) entered into by the Company with Acuity Capital Investment Management Pty Ltd atf Acuity Capital Holdings Trust, as announced to the market on 30 Apr 2019. The securities were issued as collateral shares pursuant to the CPD, which expired on 31 Jul 2023. Shareholder approval was obtained for the selective buyback on 16 Nov 2023 (see Notice of AGM dated 11 Oct 2023). Notification of buy-back 5/5